Related Experiment Video
Updated: Jul 11, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Substrate specificity of cyclins determined by electrostatics
Hui Jun Lee1, Gek Huey Chua, Arun Krishnan
1Bioinformatics Institute, Matrix, Singapore.
Abstract:
Cyclin dependent kinases (CDK) associate with cyclins to regulate cell cycle progression and gene transcription by phosphorylating key proteins. The different cyclin-CDK complexes display differences in substrate specificities with substrates binding across a shallow, hydrophobic, substrate-binding pocket known as the cyclin groove. However the mechanism underlying this differential substrate recognition remains largely unknown and cannot be explained merely on the basis of sequence variability. A subset of cyclins, cyclins A2, E1 and B1 despite being structurally and functionally similar, show marked differences in their interactions with recruitment peptides derived from their substrate or inhibitor proteins p27, p21, p57, E2F1, p53, pRb and p107. While these peptides (characterized by a cyclin binding motif of four residues ZRXL where Z and X are cationic residues) inhibit the activity of cyclins A2 and E1, no such inhibition is observed for cyclin B1. Electrostatic potentials of cyclins A2, E1 and B1 show that anionic regions of cyclins A2 and E1 enable them to bind peptides while cationic regions at homologous locations in cyclin B1 abrogate binding. These arise from charged residues that are conserved. Mutations that switch these characters are suggested. Computed energetics of binding confirms this. Deregulation of the enzymatic activity of this class of enzymes is a ubiquitous feature of human neoplasia, but attempts to exploit this therapeutically have been confounded by a lack of understanding of the precise specificity of the different cyclin complexes. Here we begin to clarify this issue by explaining the mechanism by which cyclin B1 escapes regulation by the p21 family of CDKIs.
Insights
Cyclin B1 escapes regulation by CDK inhibitors due to specific charged residues in its cyclin groove. This explains differential substrate recognition and has implications for cancer therapy.
Area of Science:
- Molecular Biology
- Biochemistry
- Structural Biology
Background:
- Cyclin-dependent kinases (CDKs) regulate cell cycle and transcription via phosphorylation.
- CDK complexes exhibit substrate specificity, influenced by the cyclin groove, but the mechanism is unclear.
- Cyclins A2, E1, and B1, though similar, show distinct interactions with substrate-derived peptides.
Purpose of the Study:
- To elucidate the mechanism of differential substrate recognition among cyclins A2, E1, and B1.
- To explain why cyclin B1 is not inhibited by p21 family of CDK inhibitors, unlike cyclins A2 and E1.
- To identify the structural basis for cyclin B1's escape from CDKI regulation.
Main Methods:
- Analysis of electrostatic potentials of cyclins A2, E1, and B1.
- Comparison of cyclin-binding motifs (ZRXL) in substrate/inhibitor peptides.
- Computational energetics of peptide-cyclin binding.
- Identification of conserved charged residues and suggested mutations.
Main Results:
- Cyclins A2 and E1 possess anionic regions in the cyclin groove that facilitate peptide binding and inhibition.
- Cyclin B1 has cationic regions at homologous positions, abrogating peptide binding and thus inhibition.
- Computed energetics confirmed the role of electrostatic interactions in differential binding.
- Specific charged residues, conserved across species, dictate the differential binding and inhibition.
Conclusions:
- The electrostatic surface potential of the cyclin groove is a key determinant of substrate/inhibitor peptide binding.
- Cyclin B1's unique cationic surface prevents inhibition by p21 family CDKIs, explaining its distinct regulatory behavior.
- Understanding these specificity mechanisms is crucial for developing targeted cancer therapies that exploit CDK deregulation.
More Related Videos
Related Concept Videos
Positive Regulator Molecules
Positive Regulator Molecules
Induced-fit Model
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical characteristics of...
Inhibition of Cdk Activity
Introduction to Mechanisms of Enzyme Catalysis
Anaphase Promoting Complex

